This trial will compare the rates of infection, pain, and detection of prostate cancer between the two biopsy methods.
1 Primary · 4 Secondary · Reporting Duration: 7 days post-biopsy
Active Control
400 Total Participants · 2 Treatment Groups
Primary Treatment: Transrectal · No Placebo Group · N/A
Age 18+ · Male Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: